TWD 21.15
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 191.83 Million TWD | 0.65% |
2022 | 190.59 Million TWD | 28.77% |
2021 | 148.01 Million TWD | -5.3% |
2020 | 156.29 Million TWD | -14.09% |
2019 | 181.93 Million TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 42.89 Million TWD | -12.25% |
2024 Q2 | 42.89 Million TWD | 0.0% |
2023 Q1 | 47.02 Million TWD | -7.54% |
2023 Q4 | 48.88 Million TWD | 0.0% |
2023 FY | 191.83 Million TWD | 0.65% |
2023 Q2 | 47.02 Million TWD | 0.0% |
2023 Q3 | 48.88 Million TWD | 3.95% |
2022 Q4 | 50.86 Million TWD | 0.0% |
2022 FY | 190.59 Million TWD | 28.77% |
2022 Q3 | 50.86 Million TWD | 0.0% |
2021 FY | 148.01 Million TWD | -5.3% |
2020 FY | 156.29 Million TWD | -14.09% |
2019 FY | 181.93 Million TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Allied Biotech Corporation | 720.43 Million TWD | 73.373% |
GeneFerm Biotechnology Co., Ltd. | 793.77 Million TWD | 75.833% |
Easywell Biomedicals, Inc. | 271.62 Million TWD | 29.378% |
TTY Biopharm Company Limited | 5.5 Billion TWD | 96.516% |
Synmosa Biopharma Corporation | 5.14 Billion TWD | 96.268% |
Orient EuroPharma Co., Ltd. | 4.59 Billion TWD | 95.822% |
Center Laboratories, Inc. | 1.39 Billion TWD | 86.239% |
Tien Liang BioTech Co., Ltd. | 459.99 Million TWD | 58.297% |
Orient Pharma Co., Ltd. | 889.91 Million TWD | 78.444% |
InnoPharmax Inc. | 46.07 Million TWD | -316.361% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 606.71 Million TWD | 68.382% |
Excelsior Biopharma Inc. | 771.56 Million TWD | 75.137% |
DV Biomed Co., Ltd. | 1.53 Billion TWD | 87.53% |
Foresee Pharmaceuticals Co., Ltd. | 195.03 Million TWD | 1.645% |
Handa Pharmaceuticals, Inc. | 1.1 Billion TWD | 82.661% |
UniPharma Co., Ltd. | 103.22 Million TWD | -85.842% |
Anxo Pharmaceutical Co., Ltd. | 939.94 Million TWD | 79.591% |
Alar Pharmaceuticals Inc. | 469.27 Million TWD | 59.122% |
Winston Medical Supply Co., Ltd. | 709.07 Million TWD | 72.946% |
Mercury Biopharmaceutical Corporation | 1.03 Million TWD | -18470.184% |
TSH Biopharm Corporation Limited | 810.91 Million TWD | 76.344% |